Characterization and quantification of major constituents of Xue Fu Zhu Yu by UPLC-DAD–MS/MS

National Commission of Chinese Pharmacopoeia, 2010, vol. 1 Li, 1998, Effect of xuefu zhuyu pill on blood stasis syndrome and risk factor of atherosclerosis, Chin. J. Integr. Med., 18, 71 Yu, 1988, Clinical and experimental study of xuefu zhuyu tang in treating qi stagnation and the blood stasis type of hyperlipidemia, Chin. J. Integr. Tradit. West. Med., 8, 601 Shi, 1992, A survey of clinical use and research of xuefu zhuyu decoction, Chin. J. Integr. Med., 12, 447 Tang, 2010, Protective effects of xuefu zhuyu decoction on myocardium ischemia reperfusion injury in rats, China J. Chin. Mater. Med., 35, 3077 Lei, 2002, Study on relationship of clinical effect of xuefu zhuyu concentrated pill and serum pharmacological anti-platelet activating effect in vitro, Chin. J. Integr. Med., 22, 270 Su, 2002, Pharmacological studies and clinical application of Xue Fu Zhu Yu decoction, Chin. Tradit. Patent Med., 24, 965 Yan, 2001, Determination of content of oleanolic acid of Xue Fu Zhu Yu wan by TLC scanning, Chin. Hosp. Pharm. J., 21, 719 Shen, 2010, Kernel Isomap Numbers-PLS modeling method and application in oral liquid extraction process of NIR spectra, Chin. Tradit. Patent Med., 32, 831 Li, 2009, FAAS determination of trace elements in Xuefuzhuyu pills, Chin. J. Pharm. Anal., 29, 150 Gao, 2010, LC–ELSD analysis for simultaneous determination of five components in the Xue Fu Zhu Yu capsules, Front. Chem. Eng. China, 4, 96, 10.1007/s11705-009-0309-z Yan, 2009, Simultaneous determination of 5 components in Xue Fu Zhu Yu oral liquid by HPLC under different UV–vis waves, Chin. J. Pharm. Anal., 29, 347 Liu, 2010, Simultaneous determination of multicomponent in Xue Fu Zhu Yu granule with different UV-wavelength by HPLC, China J. Chin. Mater. Med., 35, 2157 Gao, 2011, Simultaneous determination of nine active components in traditional Chinese medicine ‘Xue-Fu-Zhu-Yu’ capsule by HPLC–ELSD, Lat. Am. J. Pharm., 30, 281 Luan, 2006, Identification of constituents of Xue Fu Zhu Yu tang in rabbit body fluids by liquid chromatography–electro-spray mass spectrometry, Chin. Pharm. J., 41, 1252 Zhang, 2006, An HPLC/MS method for identifying major constituents in the hypocholesterolemic extracts of Chinese medicine formula Xue Fu Zhu Yu decoction, Biomed. Chromatogr., 20, 821, 10.1002/bmc.607 Zhang, 2004, Phytochemical analysis of anti-atherogenic constituents of Xue Fu Zhu Yu Tang using HPLC-DAD–ESI-MS, Chem. Pharm. Bull., 52, 1295, 10.1248/cpb.52.1295 Sun, 2009, Analysis of constituents of Xue Fu Zhu Yu tang using LC–MS spectrometry technology, Chin. Tradit. Patent Med., 31, 793 Liang, 2006, A new method for determination of kaempfero-3-O-rutinoside in plasma: application to pharmacokinetic study in Sprague-Dawley rats, Chin. J. Clin. Pharmacol. Ther., 11, 491 Ni, 2010, Analysis of chemical composition of Dachuanxiong Fang by ultra performance liquid chromatography electrospray ionization quadrupole time of flight/mass spectrometry, Chin. J. Exp. Tradit. Med. Formulae, 16, 39 Liang, 2003, Isolation and identification of the ligustilide compounds from the Root of Angelica sinensis, China J. Chin. Mater. Med., 28, 423